Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 4/20 | 0.37 |
| ▸ | GUSB | P08236 | 2/20 | 0.36 |
| ▸ | SGMS2 | Q8NHU3 | 1/20 | 0.36 |
| ▸ | BCHE | P06276 | 2/20 | 0.35 |
| ▸ | RRM1 | P23921 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | AR | P10275 | 1/20 | 0.34 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4881259 | 0.89 | MAOB (0.36) | MAOBGUSB | |
| SCHEMBL14601806 | 0.87 | MAOB (0.35) | MEN1KMT2AMAOBBCHERRM1 | |
| SCHEMBL12904940 | 0.80 | MAOB (0.36) | MEN1KMT2AMAOB | |
| Acetonitrile SCHEMBL27856444 | 0.78 | MAOB (0.37) | KMT2AMAOB | |
| SCHEMBL13073522 | 0.77 | — | — | |
| SCHEMBL22762194 | 0.76 | — | — | |
| SCHEMBL80897 | 0.76 | TSHR (0.41) | MEN1KMT2AKCNH2 | |
| SCHEMBL2229214 | 0.76 | MRGPRX4 (0.34) | MEN1KMT2A | |
| SCHEMBL27474 | 0.76 | ALDH1A1 (0.34) | MAOB | |
| SCHEMBL14601794 | 0.76 | CTSS (0.39) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070015927-A1 | New phosphoramidite compounds | POSTECH FOUNDATION (KR) | 2007-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070015927-A1 | New phosphoramidite compounds | TYMP, POLRMT, POLI | MEN1 1608/4885KMT2A 3029/4885MAOB 2735/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.